Barricade Therapeutics Launches StartEngine Crowdfunding Campaign for Colorectal Cancer Drug Development
Fort Worth based Barricade Therapeutics launched a Regulation Crowdfunding campaign on StartEngine to raise up to $1.24 million to support development of its investigational cancer therapy BT-1501, which targets APC-mutant colorectal cancer. The funds are intended to help advance the oral drug candidate into Phase 1 clinical trials and support manufacturing, research and development, and operational expenses. 
Barricade Therapeutics Launches StartEngine Crowdfunding Campaign for Colorectal Cancer Drug Development